Despite Steep Costs, Payments for New Cancer Drugs Make Economic Sense

Nature Medicine, Vol. 17, No. 244, 2011

2 Pages Posted: 26 Oct 2011

See all articles by Frank R. Lichtenberg

Frank R. Lichtenberg

Columbia Business School - Finance and Economics; National Bureau of Economic Research (NBER); CESifo (Center for Economic Studies and Ifo Institute for Economic Research)

Date Written: July 2011

Abstract

Cancer drugs have become more expensive over the past few years, leading many people to question whether the treatments are really worth their high costs. But despite the sticker shock, cancer medicines have provided good value for money.

Suggested Citation

Lichtenberg, Frank R., Despite Steep Costs, Payments for New Cancer Drugs Make Economic Sense (July 2011). Nature Medicine, Vol. 17, No. 244, 2011 , Available at SSRN: https://ssrn.com/abstract=1949303

Frank R. Lichtenberg (Contact Author)

Columbia Business School - Finance and Economics ( email )

3022 Broadway
504 Uris Hall, Dept. of Finance & Economics
New York, NY 10027
United States
212-854-4408 (Phone)
212-316-9219 (Fax)

HOME PAGE: http://https://www8.gsb.columbia.edu/cbs-directory/detail/frl1

National Bureau of Economic Research (NBER)

1050 Massachusetts Avenue
Cambridge, MA 02138
United States

CESifo (Center for Economic Studies and Ifo Institute for Economic Research)

Poschinger Str. 5
Munich, DE-81679
Germany

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
92
Abstract Views
465
rank
304,552
PlumX Metrics